Medicrea reports Q1 sales of $7.43M — 3 takeaways

Lyon, France-based Medicrea reported quarter one 2017 sales of $7.43 million.

Advertisement

Here are three takeaways:

 

1. Medicrea saw a 38 percent increase in U.S. cases leveraging the UNiD Rods.

 

2. In Q1, the company moved all manufacturing operations from its La Rochelle site to a new facility in Rillieux-la-Pape.

 

3. The company will highlight its UNiD Adaptive Spine Intelligence and patient-specific implants at the International Society for the Advancement of Spine Surgery annual meeting, in Boca Raton, Fla., from April 12 to 14.

 

More articles on devices:
Medical device industry outlook in 2017: 5 thoughts from AdvaMed President and CEO Scott Whitaker
Bridging the gap between new spine technology & patients — The role of the Medical Science Liaison
Meeting to highlight 9M implanted PEEK-OPTIMA devices & more: 5 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.